points out that in a large proportion of chemotherapeutic cures "the infection is brought to an end by stopping the further multiplication of the parasites, rather than by killing them outright. Another factor in an effective chemotherapeutic action ... [is] the need for a sufficiently prolonged and continuous action. This need is almost implied in the conception of the process as essentially an arrest of the multiplication of the parasites rather than an immediately lethal action on them. What is required is not the sudden attainment of a concentration sufficient to kill most of the parasites, at the risk of a concomitant injury to the host's tissues, but the long-continued maintenance of a much lower and safer concentration, just sufficient to suppress the propagation of the parasites, without harming the cells of the host."
Evidence with respect to the mode of action of successful chemotherapeutic agents is in agreement with the original conception of Ehrlich and with Dale's conclusion that they act essentially by arrest of the multiplication of the parasites. A definition of objective then becomes possible. For successful chemotherapy of an infection due to an intracellular parasite there may be sought a metabolic inhibitor or inhibitors which selectively inhibit a reaction or reactions essential to the intracellular multiplication of the parasite, but (at least temporarily) inessential to the survival of the host cell.2
Concerning the mechanism of action of the sulfonamides two theories are current:
(1) The Woods-Fildes theory that sulfonamides inhibit an enzyme or enzymes concerned with the anabolism of p-aminobenzoic acid as an essential metabolite.
(2) The theory proposed chiefly by Sevag and coworkers (1942) that sulfonamides act by inhibiting in the susceptible bacteria certain respiratory enzymes which normally mediate reactions yielding the energy essential to bacterial cell division.
The fundamental proposition that substances similar to but not identical in configuration with particular components in a metabolic reaction can compete for essential reaction sites and thereby inhibit the metabolic reaction is not questioned. (See Fildes, 1940 Woods, 1940; Roblin et al., 1945, for references.) This fundamental principle is valid and applicable, however, whether the enzyme inhibitor resembles and competes with a substrate, or, in the case of the oxidative enzymes, with a coenzyme. The Woods-Fildes theory has been of the utmost importance in emphasizing configurational correspondence as a basis for enzyme inbibition in chemotherapy, and in stimulating the discovery of new instances and applications (e.g., see Mcllwain, 1944; Woolley, 1944) . In the writer's belief, however, the balance of evidence very definitely now indicates that in the special case of the mechanism of sulfonamide action the critical competition is with respiratory coenzymes for sites on the oxidative enzyme proteins rather than for a hypothetical enzyme mediating p-aminobenzoic acid anabolism. The subject is comprehensively reviewed by Sevag and coworkers (1942 Sevag and coworkers ( , 1944 Sevag and coworkers ( , 1945 and Henry (1943 Henry ( , 1944 .
Examination of such literature as is available on the mode of action of chemotherapeutic agents leads, at least tentatively, to the challenging conclusion that in cases in which critical enzyme inhibitions correlated with inhibition of growth have been identified experimentally, these critical sites of chemotherapeutic action have been found to be within the system of respiratory enzymes which mediate the aerobic and anaerobic oxidation of glucose and its derivatives.
The respiratory enzymes are proteins reversibly combined with coenzymes; the coenzymes contain as essential structural units certain components of the B vitamin complex, notably nicotinic acid amide, riboflavin, and thiamine; or, in the case of the cytochrome-cytochrome oxidase system, the iron porphyrin compound heme is the prosthetic group. These relationships may be represented schematically as in figure 1. Thiamine for instance becomes by phosphorylation cocarboxylase (thiamine diphosphate) and riboflavin becomes riboflavin phosphoric acid. The enzyme carrier protein combines reversibly with its coenzyme and specific substrate, thus enabling the substrate to reduce the coenzyme, the substrate itself being oxidized.
We suppose that sulfanilamide has affinity for the respiratory enzyme protein3
I In this connection the similarity of structure of sulfanilamide to other pharmacologically active substances is of interest. Compare for instance the structure of p-aminobenzenesulfonamide with that of the p-aminophenol derivatives (antipyretics and analgesics), procaine, ethyl and butyl p-aminobenzoates (local anesthetics), carbarsone (amebacide), and tryparsamide (trypanocide). It is suggested that widely distributed reaction sites exist with which compounds possessing the general configuration of p-aminobenzenesulfonamides, p-aminobenzoates, and p-aminophenylarsonates and their appropriate derivatives can combine reversibly with a resulting depressant effect. It is suggested that these reaction sites on oxidative enzyme proteins are of critical significance in chemotherapy.
However, in calling attention in this address to interrelationships based upon configurational correspondence, no implication is intended that all cases of inhibition and antagonism involve such configurational correspondence, which is obviously not true. In enzyme chemistry as in immunochemistry, however, the interrelationships depending upon specific configuration are perhaps more interesting and more stimulating to further discovery than those involving only nonspecific relationships. and is supplemented in the newer sulfonamides by the N' substituted group (pyridine, thiazole, pyrimidine) whieh structurally resembles the coenzyme or part of it, and competes with the coenzyme for its reaction site on the enzyme protein. (See figures 1, 2, and 3 .) The proposal herewith suggested is that the sulfanilamide and the N" substituted group are capable of combining, respectively, at two reaction sites, in appropriate steric relationship, on the enzyme protein. Such a proposal is not without analogy since dipeptidase action is believed to depend on three reaction sites on the enzyme in v-ery definite steric relationship (Schmidt, 1938) . The drug-protein or drug-protein-coenzyme complex we suppose to be inactive enzymatically. Quantitative antagonism between drug and coenzyme thus becomes understandable, and similarly antagonism between vitamin and drug, since the v-itamin is a precursor of the corresponding coenzyme.. The superiority of sulfapyridine, sulfathiazole, and sulfadiazine over sulfanilamide is intelligible in these terms but difficult to account for on the p-aminobenzoic acid theory.
The following critical sites of chemotherapeutic action may be cited as indicated by experiment.
Dorfman an_d Koser (1942) showed that the respiration of dysentery bacilli was increased by nicotinamide and inhibited by sulfapyridine (cf. figure 2) . MacLeod (1939) found that the dehydrogenase activity of pneumococci for glycerol, lactate, and pyruvate was inhibited by sulfapyridine. Acquisition of sulfapyridine fastness was associated with marked loss of dehydrogenase activity for these compounds. Fox (1942) working with isolated enzyme systems of Eschcrichia coli demonstrated inhibition of lactate, aerobically, and dismutation of pyruvate, anaerobically.
Flavoprotein dehydrogenases (riboflavin phosphoric acid proteins). Sevag and Green (1944) found that growth of certain strains of Staphylococcus aureus in the absence of added glucose is inhibited by sulfathiazole, and that this inhibition is antagonized by riboflavin. Atabrine has been shown by Haas (1944) , working with isolated enzyme systems of yeast, to inhibit oxidation mediated by flavoprotein, and this inhibition is antagonized by the coenzyme (cf. figure 3) . Selective inhibition of flavoprotein enzyme systems by atabrine has been indicated by tissue respiration experiments (Wright and Sabine, 1944) .
Carboxylase (thiamine pyrophosphate protein). Sevag, Shelburnc, and Mudd (1942, 1945) found that sulfathiazole selectively inhibits the action of carboxylase from both yeast and staphylococcus; this inhibition is antagonized by cocarboxylase (cf. figure 2) . Penicillin has been shown by Welshimer, Krampitz, and Werkman (1944) to inhibit selectively the dismutation of pyruvic acid.
Cytochrome-cytochromc oxidase system (heme-containing enzymes). Cytochrome oxidase has been shown by Haas (1944) to be inhibited by atabrine. Zephiran has been shown by Sevag and Ross (1944) to inhibit the cytochromecytochrome oxidase system of yeast cells, and this action is correlated with inhibition of growth. These are probably instances of nonspecific inhibition.
The Pasteur effect has been shown to be strongly inhibited by certain substituted guanidines and amidines which are powerful trypanocides (Dickens, 1939) . .= e
Steps in the enzymatic oxidation of glucose thuis represent critical sources of the energy required for cell division, which may be vulnerable to the action of chemotherapeutic agents. In view of the great clinical success of the sulfonamides in which pyridine, thiazole, and pyrimidine are substituents on the N' nitrogen of sulfanilamide, and of the relationships schematized, it would be extremely interesting to have series of sulfonamides in which alloxazine, atabrine, or acridine are substituents on the N' nitrogen of sulfanilamide4 (figure 3). Because of the critical role in glucose oxidation of phosphorylation, mediated by the adenosine phosphoric acid enzymes, it would be exceedingly interesting also to have series of sulfonamides in which adenine and adenosine are similarly coupled with sulfanilamide.
The oxidations of glucose into its intermediate products, however, may proceed by several different pathways (for details see Potter, 1944) (Ungar, 1943; Bigger, 1944; Soo-Hoo and Schnitzer, 1944; Harned, Miller, Wiener, and Watts, 1944; T'ung, 1944; Kirby, 1944; Hobby and Dawson, 1945; Roblin et al., 1945) . However, since synergistic action producing multiple inhibitions on host cell enzymes essential to intracellular multiplication of the parasite might be also injurious to the host, any application of this type of study to man, pending thorough investigation in vitro and in animals, would seem premature and dangerous.
The investigation of bacterial respiratory and other metabolic systems as a basis for a rational chemotherapy will bring our discipline into close association with studies of nutrition, normal and abnormal growth, and the physiology of muscular, nervous, and glandular function. The mature synthesis which will eventually result will surely make manifold return in understanding of fundamental life processes and in applications to human well-being.
In the acridine derivatives listed by Northey (1940) substitution was on the N4 nitrogen.
Pyrazine, which forms the central ring of riboflavin, has been used in the pyrazine analog of sulfapyridine (Ellingson, 1941) . Sulfapyrazine is reported to be of the same order of efficacy as sulfadiazine (Robinson, Siegel, and Graessle, 1943 ).
After the above was wvritten, Dr. E. II. Northey kindly furnished the writer references recording the synthesis of acridine derivatives of sulfanilamide (Ganapathi and Nandi, 1940; Das-Gupta, 1941; Coggeshall and Maier, 1942) . Ganapathi (1940) Ganapathi (1941) has also recorded the synthesis of 7-N'-sulphanilamidoalloxazine which he reported to be therapeutically inactive in mice. It does not followv of course that amoing related (lerivatives an active one might not be found.
